Qiming, Legend Lead $14M Series B Round In Chinese Clinic Operator QSICM

Jillian Yue
April 17, 2017 — 21:27 CST

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!

Already have an account or paid subscription? Log in

Related Topics: Chengdu china healthcare chinese finance Franchise healthcare Legend Capital medicine pharmaceutical qiming Qiming Venture Partners QSICM Shaanxi venture capital

Related News:

Saudi Arabia’s FoFs Jada Backs eWTP Arabia Capital’s Second Fund

December 9, 2023 — 02:30

Chinese Charitable Foundations Expand Into Alternative Investments To Enhance Returns

November 30, 2023 — 23:50

Chinese Generative AI Startups Secure Substantial Funding in Race to Replicate OpenAI’s Success

November 13, 2023 — 23:55

Middle Eastern Sovereign Wealth Funds Deepen Investment in China

November 10, 2023 — 23:35

Reports Indicate NVIDIA Tailoring Specialized Chips for China’s Market

November 9, 2023 — 23:26

Kai-Fu Lee’s AI Firm 01.AI Hits Unicorn Status with Alibaba Cloud-Led Funding

November 7, 2023 — 00:55

AI-Driven Pharmaceutical Startups Attract Soaring Investor Interest

November 5, 2023 — 03:24

China’s Venture Mega-Deals 2019 to 2022 In One Chart: Can It Last?

April 15, 2022 — 00:30

NIO Capital Secures US$400 Million For Second USD Fund

March 22, 2022 — 03:16

Franchising and Licensing Asia (FLAsia) 2024